• mansion88明升(中国)

    SARS-CoV Nucleoprotein / NP Antibody, Mouse MAb

      ◎当前位置:mansion88明升(中国)>>新型冠状病毒产品合集>>新型冠状病毒相关抗体产品
    GENERAL INFORMATION
    Immunogen: Recombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
    Preparation This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant SARS-CoV Nucleoprotein / NP (Catalog#40143-V08B; NP_828858.1; Met1-Ala422). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
    Ig Type: Mouse IgG1
    Clone ID 08
    Specificity: SARS-CoV Nucleoprotein / NP
    Has cross-reactivity in ELISA and WB with SARS-CoV-2 (2019-nCoV) Nucleoprotein / NP Protein (Cat# 40588-V08B).
    Formulation: 0.2 μm filtered solution in PBS
    Storage: This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. PreservativeFree. Avoid repeated freeze-thaw cycles.
    Alternative Names: NP
    APPLICATIONS
    Applications: WB、ELISA, FCM, ICC/IF, IHC-P, IP
      (Antibody's applications have not been validated with corresponding viruses. Optimal concentrations/dilutions should be determined by the end user.)
    RECOMMENDED CONCENTRATION
    WB WB: 1:1000-1:5000
    ELISA ELISA: 1:5000-1:10000
    This antibody can be used at 1:5000-1:10000 with the appropriate secondary reagents to detect SARSCoV Nucleoprotein / NP.
    Please Note: Optimal concentrations/dilutions should be determined by the end user.

    产品图

    Anti-SARS-NP mouse
    monoclonal antibody at 1:1000 dilution.

    Lane A: SARS-CoV NP Protein (Cat#40143-V08B) (30ng)
    Lane B: SARS-CoV NP Protein (Cat#40143-V08B) (5ng)
    Lane C: SARS-CoV-2 (2019-nCoV) NP Protein
    (Cat#40588-V08B) (30ng)
    Lane D: SARS-CoV-2 (2019-nCoV) NP Protein
    (Cat#40588-V08B) (5ng)

    Secondary
    Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution.

    Developed using the ECL technique.
    Performed under reducing conditions.



    热门栏目您可能对以下内容感兴趣:

    新型冠状病毒产品合集